PAHC

Phibro Animal Health Corporation

Price

$39.57

return (12m)

0.42%

p/e

15.71

p/bv

4.07

DIVIDEND YIELD

1.24%

PAHC price

Phibro Animal Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment PAHC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.97%

3 months

19.29%

1 year

0.42%

2 years

68.78%

5 years

102.63%

10 years

89.49%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PAHC

Valuation

P/E

15.71

Sector -3.10

Industry -3.10

P/BV

4.07

Sector 1.77

Industry 1.77

P/Revenue (PSR)

1.03

Sector 2.01

Industry 2.01

EV/EBITDA

37.22

Sector -216.68

Industry -216.68

EV/EBIT

48.92

Sector -46.14

Industry -46.14

P/EBITDA

6.73

Sector -21.54

Industry -21.54

P/EBIT

8.64

Sector -27.94

Industry -27.94

P/Total Assets

1.04

Sector 1.05

Industry 1.05

P/Net Current Assets

-8.69

Sector -9.24

Industry -9.24

P/Working Capital

2.53

Sector -135.45

Industry -135.45

EPS

2.46

Sector -1.78

Industry -1.78

BVPS

9.50

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

33.76%

Sector 41.24%

Industry 41.24%

EBITDA Margin

14.06%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

12.81%

Sector -35.37%

Industry -35.37%

Net Profit Margins

6.57%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.26

Sector 0.03

Industry 0.03

Profitability

ROE

25.87%

Sector -57.47%

Industry -57.47%

ROA

6.64%

Sector -59.48%

Industry -59.48%

ROIC

10.63%

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

1.24%

Sector -

Industry -

Payout

19.48%

Sector -

Industry -

Debt

Current Ratio

2.96

Sector 2.92

Industry 2.92

Net Debt / EBITDA

9.14

Sector -21.38

Industry -21.38

Net Debt / EBIT

12.01

Sector -8.29

Industry -8.29

Net Debt / Equity

1.32

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

1.54

Sector -0.84

Industry -0.84

Equity/Assets

0.26

Sector 0.46

Industry 0.46

Liabilities/Assets

0.74

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

11.54%

Sector -

Industry -

5Y Earnings CAGR

13.36%

Sector -

Industry -

Fundamentals PAHC

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Phibro Animal Health ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$39.57

Fair Value

$22.93

Upside

-42.05%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PAHC Phibro Animal Health Corporation	$39.57	0.42%	1.24%	15.71	4.07	25.87%	6.57%
PFE Pfizer Inc.	$29.30	29.93%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$283.02	27.22%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.44	-25.78%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$144.69	75.65%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$165.06	-0.87%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$58.66	42.28%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.45	-43.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$426.52	46.68%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$782.52	35.91%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$122.82	83.23%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$994.67	27.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$502.58	20.58%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$250.05	61.38%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$820.58	-2.74%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$37.50	44.79%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$232.87	62.85%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PAHC - Historical Dividends

Current Dividend Yield

1.24%

5-year average Dividend Yield

2.90%

Current Payout

19.48%

5-year average Payout

65.28%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/01/2026	09/23/2026	0.12000000
Dividends	06/02/2026	06/24/2026	0.12000000
Dividends	03/03/2026	03/25/2026	0.12000000
Dividends	11/25/2025	12/17/2025	0.12000000
Dividends	09/02/2025	09/24/2025	0.12000000
Dividends	06/03/2025	06/25/2025	0.12000000
Dividends	03/04/2025	03/26/2025	0.12000000
Dividends	11/26/2024	12/18/2024	0.12000000
Dividends	09/03/2024	09/25/2024	0.12000000
Dividends	06/05/2024	06/26/2024	0.12000000
Dividends	03/04/2024	03/27/2024	0.12000000
Dividends	11/27/2023	12/20/2023	0.12000000
Dividends	09/04/2023	09/27/2023	0.12000000
Dividends	06/05/2023	06/28/2023	0.12000000
Dividends	02/27/2023	03/22/2023	0.12000000
Dividends	11/28/2022	12/21/2022	0.12000000
Dividends	09/05/2022	09/28/2022	0.12000000
Dividends	05/30/2022	06/22/2022	0.12000000
Dividends	02/28/2022	03/23/2022	0.12000000
Dividends	11/22/2021	12/15/2021	0.12000000
Dividends	08/30/2021	09/22/2021	0.12000000
Dividends	05/31/2021	06/23/2021	0.12000000
Dividends	03/01/2021	03/24/2021	0.12000000
Dividends	11/23/2020	12/16/2020	0.12000000
Dividends	08/31/2020	09/23/2020	0.12000000
Dividends	06/01/2020	06/24/2020	0.12000000
Dividends	03/02/2020	03/25/2020	0.12000000
Dividends	11/25/2019	12/18/2019	0.12000000
Dividends	09/02/2019	09/25/2019	0.12000000
Dividends	06/03/2019	06/26/2019	0.12000000
Dividends	03/04/2019	03/27/2019	0.12000000
Dividends	11/26/2018	12/19/2018	0.12000000
Dividends	09/03/2018	09/26/2018	0.10000000
Dividends	06/04/2018	06/27/2018	0.10000000
Dividends	03/05/2018	03/28/2018	0.10000000
Dividends	12/04/2017	12/27/2017	0.10000000
Dividends	09/04/2017	09/27/2017	0.10000000
Dividends	05/29/2017	06/22/2017	0.10000000
Dividends	02/27/2017	03/22/2017	0.10000000
Dividends	11/28/2016	12/21/2016	0.10000000
Dividends	09/05/2016	09/28/2016	0.10000000
Dividends	05/30/2016	06/22/2016	0.10000000
Dividends	02/29/2016	03/23/2016	0.10000000
Dividends	11/30/2015	12/23/2015	0.10000000
Dividends	08/31/2015	09/23/2015	0.10000000
Dividends	06/01/2015	06/24/2015	0.10000000
Dividends	03/02/2015	03/25/2015	0.10000000
Dividends	12/01/2014	12/23/2014	0.10000000
Dividends	09/01/2014	09/24/2014	0.10000000

ABOUT Phibro Animal Health

Phibro Animal Health Corporation

Average Investor10 user rating

4.0 (5 people)

United States

12 years

Founded: 2014

2014

Time since IPO - 12 years

1.725

Employees

Phibro Animal Health Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.57 billion, with shareholders equity totaling $385.48 million.

The company employs approximately 1.725 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Phibro Animal Health Corporation reported $1.52 billion in revenue, generating net income of $99.72 million.

Key financial metrics include a P/E ratio of 15.71, a price-to-book (P/B) ratio of 4.07, and a trailing twelve-month dividend yield of 1.24%.

The company trades under the ticker PAHC.

Market cap

$1.57 billion

Net worth

$385.48 million

$385,477,000.00

Assets

$1.50 billion

$1,501,241,000.00

Total Shares Outstanding

40.56 million

40,564,000

Average Daily Trading Volume

$234.11 Thousand

$234,108.80

Sector

Health Care

Industry

Biotechnology

PAHC

PAHC revenue and profits

Financial Results PAHC

DRAG THE FRAME TO SEE MORE DATA

PAHC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.67 27,04% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$250.05 61,38% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$283.02 27,22% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$144.69 75,65% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$165.06 0,10% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$29.30 29,93% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.67 27,04% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$250.05 61,38% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$283.02 27,22% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$144.69 75,65% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$165.06 0,10% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$29.30 29,93% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of Phibro Animal Health (PAHC) today?

The current price of Phibro Animal Health (PAHC) is $39.57. The stock began the year trading around $37.36 and is currently priced at $39.57. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Phibro Animal Health (PAHC) pay dividends?

Phibro Animal Health (PAHC) distributed dividends in the last year, in the months of March, June and September totaling $0.36. The Dividend Yield for the last 12 months is 1.24%.

Is Phibro Animal Health (PAHC) a good investment?

Phibro Animal Health (PAHC) is currently trading at $39.57 with a P/E ratio of 15.71. This represents a 2,383% premium compared to its historical average P/E. Over the past year, the stock paid $0.36 in dividends, resulting in a dividend yield of 1.24%. The total shareholder return over the same period was 0.42%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Phibro Animal Health (PAHC) stock?

You can buy Phibro Animal Health (PAHC) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PAHC and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Phibro Animal Health (PAHC) yield today?

Over the past month, Phibro Animal Health (PAHC) has returned 11.97% — 0.42% over the past year, and 102.63% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.48 per share in dividends, resulting in a dividend yield of 1.24%.

If you were to purchase 100 shares of Phibro Animal Health (PAHC) today at the current price of $39.57 your total investment would be $3,957.00.

Based on historical performance, the investment would have grown to approximately:

$3,973.62 after 1 year
$8,018.07 after 5 years
$7,498.12 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PAHC

Phibro Animal Health Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PAHC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING PAHC WITH OTHER STOCK

type

Ex - Dividend Date

payment date

value

ABOUT Phibro Animal Health

Phibro Animal Health Corporation

United States

12 years

2014

1.725

PROFIT X PRICE PAHC

Financial Results PAHC

PAHC cash flow

Asset, Revenue and Profit Growth - PAHC

PAHC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions